Shannon One Designs Emerge Refreshed From Their Action-Packed Twin Centenary Regattas
Lough Ree mostly laid on two days of lively clearview sailing
Source: afloat.ie
Page 3 - Alex Leech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alex Leech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alex Leech Today - Breaking & Trending Today
Lough Derg Yacht Club Serves Up Full Set of Results For Four Keelboat Classes
LDYC Commodore Joe Gilmartin welcomed a strong fleet across four keelboat classes
Source: afloat.ie
60 Youth Sailors Gather at Lough Ree For Inaugural Double Handed Sailing Symposium
The weekend culminated on Sunday with racing but of course nothing ordinary!
Source: afloat.ie
Alchemab raises 60M ($82M) in Series A financing to advance novel platform for identifying disease-modifying antibody therapeutics
Posted on 802 Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, today announces the completion of a £60 million ($82 million) Series A financing round. The international investment syndicate is led by RA Capital Management, with participation from Lightstone Ventures, Data Collective VC (DCVC), DHVC, SV Health Investors and the Dementia Discovery Fund. The company was created by SV Health Investors who led the Seed...
Source: financialbuzz.com
Alchemab Therapeutics Raises £60M in Series A Financing
Alchemab Therapeutics Raises £60M in Series A Financing Alchemab Therapeutics, a Cambridge, England, UK-based biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies, completed a £60m ($82m) Series A financing round. The round was led by RA Capital Management, with participation from Lightstone Ventures, Data Collective VC (DCVC), DHVC, SV Health Investors and the Dementia Discovery Fund. The company, which was created by SV Health Investors who led the Seed round in 2019, intends to use the advance its target-agnostic drug discove...
Source: finsmes.com